Literature DB >> 23455637

A variant in FTO shows association with melanoma risk not due to BMI.

Mark M Iles1, Matthew H Law, Simon N Stacey, Jiali Han, Shenying Fang, Ruth Pfeiffer, Mark Harland, Stuart Macgregor, John C Taylor, Katja K Aben, Lars A Akslen, Marie-Françoise Avril, Esther Azizi, Bert Bakker, Kristrun R Benediktsdottir, Wilma Bergman, Giovanna Bianchi Scarrà, Kevin M Brown, Donato Calista, Valérie Chaudru, Maria Concetta Fargnoli, Anne E Cust, Florence Demenais, Anne C de Waal, Tadeusz Dębniak, David E Elder, Eitan Friedman, Pilar Galan, Paola Ghiorzo, Elizabeth M Gillanders, Alisa M Goldstein, Nelleke A Gruis, Johan Hansson, Per Helsing, Marko Hočevar, Veronica Höiom, John L Hopper, Christian Ingvar, Marjolein Janssen, Mark A Jenkins, Peter A Kanetsky, Lambertus A Kiemeney, Julie Lang, G Mark Lathrop, Sancy Leachman, Jeffrey E Lee, Jan Lubiński, Rona M Mackie, Graham J Mann, Nicholas G Martin, Jose I Mayordomo, Anders Molven, Suzanne Mulder, Eduardo Nagore, Srdjan Novaković, Ichiro Okamoto, Jon H Olafsson, Håkan Olsson, Hubert Pehamberger, Ketty Peris, Maria Pilar Grasa, Dolores Planelles, Susana Puig, Joan Anton Puig-Butille, Juliette Randerson-Moor, Celia Requena, Licia Rivoltini, Monica Rodolfo, Mario Santinami, Bardur Sigurgeirsson, Helen Snowden, Fengju Song, Patrick Sulem, Kristin Thorisdottir, Rainer Tuominen, Patricia Van Belle, Nienke van der Stoep, Michelle M van Rossum, Qingyi Wei, Judith Wendt, Diana Zelenika, Mingfeng Zhang, Maria Teresa Landi, Gudmar Thorleifsson, D Timothy Bishop, Christopher I Amos, Nicholas K Hayward, Kari Stefansson, Julia A Newton Bishop, Jennifer H Barrett.   

Abstract

We report the results of an association study of melanoma that is based on the genome-wide imputation of the genotypes of 1,353 cases and 3,566 controls of European origin conducted by the GenoMEL consortium. This revealed an association between several SNPs in intron 8 of the FTO gene, including rs16953002, which replicated using 12,313 cases and 55,667 controls of European ancestry from Europe, the USA and Australia (combined P = 3.6 × 10(-12), per-allele odds ratio for allele A = 1.16). In addition to identifying a new melanoma-susceptibility locus, this is to our knowledge the first study to identify and replicate an association with SNPs in FTO not related to body mass index (BMI). These SNPs are not in intron 1 (the BMI-related region) and exhibit no association with BMI. This suggests FTO's function may be broader than the existing paradigm that FTO variants influence multiple traits only through their associations with BMI and obesity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23455637      PMCID: PMC3640814          DOI: 10.1038/ng.2571

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  46 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Pigmentary characteristics and moles in relation to melanoma risk.

Authors:  Linda Titus-Ernstoff; Ann E Perry; Steven K Spencer; Jennifer J Gibson; Bernard F Cole; Marc S Ernstoff
Journal:  Int J Cancer       Date:  2005-08-10       Impact factor: 7.396

Review 3.  Genetic predisposition to cancer.

Authors:  L A Cannon-Albright; D T Bishop; C Goldgar; M H Skolnick
Journal:  Important Adv Oncol       Date:  1991

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer.

Authors:  J H Barrett; G Smith; R Waxman; N Gooderham; T Lightfoot; R C Garner; K Augustsson; C R Wolf; D T Bishop; D Forman
Journal:  Carcinogenesis       Date:  2003-02       Impact factor: 4.944

6.  Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy.

Authors:  Luigi Naldi; Andrea Altieri; Gian Lorenzo Imberti; Laura Giordano; Silvano Gallus; Carlo La Vecchia
Journal:  Ann Epidemiol       Date:  2005-08       Impact factor: 3.797

7.  Genome-wide association study identifies three loci associated with melanoma risk.

Authors:  D Timothy Bishop; Florence Demenais; Mark M Iles; Mark Harland; John C Taylor; Eve Corda; Juliette Randerson-Moor; Joanne F Aitken; Marie-Francoise Avril; Esther Azizi; Bert Bakker; Giovanna Bianchi-Scarrà; Brigitte Bressac-de Paillerets; Donato Calista; Lisa A Cannon-Albright; Thomas Chin-A-Woeng; Tadeusz Debniak; Gilli Galore-Haskel; Paola Ghiorzo; Ivo Gut; Johan Hansson; Marko Hocevar; Veronica Höiom; John L Hopper; Christian Ingvar; Peter A Kanetsky; Richard F Kefford; Maria Teresa Landi; Julie Lang; Jan Lubiński; Rona Mackie; Josep Malvehy; Graham J Mann; Nicholas G Martin; Grant W Montgomery; Frans A van Nieuwpoort; Srdjan Novakovic; Håkan Olsson; Susana Puig; Marjan Weiss; Wilbert van Workum; Diana Zelenika; Kevin M Brown; Alisa M Goldstein; Elizabeth M Gillanders; Anne Boland; Pilar Galan; David E Elder; Nelleke A Gruis; Nicholas K Hayward; G Mark Lathrop; Jennifer H Barrett; Julia A Newton Bishop
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

8.  Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light.

Authors:  E A Holly; D A Aston; R D Cress; D K Ahn; J J Kristiansen
Journal:  Am J Epidemiol       Date:  1995-05-15       Impact factor: 4.897

9.  A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.

Authors:  Timothy M Frayling; Nicholas J Timpson; Michael N Weedon; Eleftheria Zeggini; Rachel M Freathy; Cecilia M Lindgren; John R B Perry; Katherine S Elliott; Hana Lango; Nigel W Rayner; Beverley Shields; Lorna W Harries; Jeffrey C Barrett; Sian Ellard; Christopher J Groves; Bridget Knight; Ann-Marie Patch; Andrew R Ness; Shah Ebrahim; Debbie A Lawlor; Susan M Ring; Yoav Ben-Shlomo; Marjo-Riitta Jarvelin; Ulla Sovio; Amanda J Bennett; David Melzer; Luigi Ferrucci; Ruth J F Loos; Inês Barroso; Nicholas J Wareham; Fredrik Karpe; Katharine R Owen; Lon R Cardon; Mark Walker; Graham A Hitman; Colin N A Palmer; Alex S F Doney; Andrew D Morris; George Davey Smith; Andrew T Hattersley; Mark I McCarthy
Journal:  Science       Date:  2007-04-12       Impact factor: 47.728

10.  Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.

Authors:  V Bataille; J A Bishop; P Sasieni; A J Swerdlow; E Pinney; K Griffiths; J Cuzick
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

View more
  61 in total

1.  Association between the FTOrs8050136 polymorphism and cancer risk: a meta-analysis.

Authors:  Jian Zhao; Xiaoyi Huang; Mingyuan Yang; Ming Li; Jianming Zheng
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

2.  Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth.

Authors:  Siyuan Xia; Ruiting Lin; Lingtao Jin; Liang Zhao; Hee-Bum Kang; Yaozhu Pan; Shuangping Liu; Guoqing Qian; Zhiyu Qian; Evmorfia Konstantakou; Baotong Zhang; Jin-Tang Dong; Young Rock Chung; Omar Abdel-Wahab; Taha Merghoub; Lu Zhou; Ragini R Kudchadkar; David H Lawson; Hanna J Khoury; Fadlo R Khuri; Lawrence H Boise; Sagar Lonial; Benjamin H Lee; Brian P Pollack; Jack L Arbiser; Jun Fan; Qun-Ying Lei; Jing Chen
Journal:  Cell Metab       Date:  2017-01-12       Impact factor: 27.287

3.  Updated field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma: the MelGene database.

Authors:  Kyriaki Antonopoulou; Irene Stefanaki; Christina M Lill; Foteini Chatzinasiou; Katerina P Kypreou; Fani Karagianni; Emmanouil Athanasiadis; George M Spyrou; John P A Ioannidis; Lars Bertram; Evangelos Evangelou; Alexander J Stratigos
Journal:  J Invest Dermatol       Date:  2014-11-19       Impact factor: 8.551

Review 4.  Novel RNA modifications in the nervous system: form and function.

Authors:  John S Satterlee; Maria Basanta-Sanchez; Sandra Blanco; Jin Billy Li; Kate Meyer; Jonathan Pollock; Ghazaleh Sadri-Vakili; Agnieszka Rybak-Wolf
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

5.  A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF.

Authors:  Jiyeon Choi; Mai Xu; Matthew M Makowski; Tongwu Zhang; Matthew H Law; Michael A Kovacs; Anton Granzhan; Wendy J Kim; Hemang Parikh; Michael Gartside; Jeffrey M Trent; Marie-Paule Teulade-Fichou; Mark M Iles; Julia A Newton-Bishop; D Timothy Bishop; Stuart MacGregor; Nicholas K Hayward; Michiel Vermeulen; Kevin M Brown
Journal:  Nat Genet       Date:  2017-07-31       Impact factor: 38.330

6.  Reversible RNA modifications in meiosis and pluripotency.

Authors:  Arne Klungland; John Arne Dahl; Gareth Greggains; Peter Fedorcsak; Adam Filipczyk
Journal:  Nat Methods       Date:  2016-12-29       Impact factor: 28.547

Review 7.  Update in genetic susceptibility in melanoma.

Authors:  Miriam Potrony; Celia Badenas; Paula Aguilera; Joan Anton Puig-Butille; Cristina Carrera; Josep Malvehy; Susana Puig
Journal:  Ann Transl Med       Date:  2015-09

Review 8.  The dynamic epitranscriptome: N6-methyladenosine and gene expression control.

Authors:  Kate D Meyer; Samie R Jaffrey
Journal:  Nat Rev Mol Cell Biol       Date:  2014-04-09       Impact factor: 94.444

Review 9.  The Epitranscriptome of Noncoding RNAs in Cancer.

Authors:  Manel Esteller; Pier Paolo Pandolfi
Journal:  Cancer Discov       Date:  2017-03-20       Impact factor: 39.397

10.  Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.

Authors:  Nancy E Thomas; Sharon N Edmiston; Irene Orlow; Peter A Kanetsky; Li Luo; David C Gibbs; Eloise A Parrish; Honglin Hao; Klaus J Busam; Bruce K Armstrong; Anne Kricker; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2018-05-09       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.